SAN FRANCISCO, Jan 12 () - Amgen's research chief said the company is very confident about its experimental obesity drug ...

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Apply to become a Senior Planet sponsored athlete to motivate ...

With Christmas credit card bills starting to arrive and the cost of December last year beginning to bite, January can be a ...

There’s a well-worn pattern in the development of AI chatbots. Researchers discover a vulnerability and exploit it to do ...

It’s the latest move in the race by drug companies to corner more of the highly lucrative obesity drug market.

Shares of LifeMD rose after the virtual-healthcare company said it would offer Novo Nordisk's weight-loss pill, Wegovy. The stock was up 15% at about midday. Shares have risen around 18% year to date.

GoodRX, Weight Watchers and LifeMD all said they will offer Novo Nordisk's new weight-loss pill, Wegovy, on their respective platforms. U.S. regulators approved the new pill last month. At that time, ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

Every state in the nation is set to receive a portion of a massive $50 billion federal investment aimed at stabilizing rural ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

GitHub's CodeQL 2.23.0 release introduces enhanced security detection, including a new Rust log injection query, improved data flow analysis, and faster extraction processes. GitHub has announced the ...